American Healthcare REIT vs Welltower
AHR and WELL side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AHR and WELL compare
Welltower is the larger company, worth 14 times as much as American Healthcare REIT ($169B against $11.7B).
On earnings, American Healthcare REIT is cheaper: it trades at 78.7× trailing earnings, against 108× for Welltower.
Welltower grew revenue faster over the last twelve months (37.6% versus 16.4% for American Healthcare REIT).
Both pay dividends: American Healthcare REIT yields 1.9% and Welltower 1.3%.
American Healthcare REIT scores higher on the StockData Score (11 against 10 for Welltower), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AHR | WELL |
|---|---|---|
| Size and price | ||
| Market cap | $11.7B | $169B |
| Share price | $53.52 | $234.60 |
| Change, 1 year | 20.1% | 32.6% |
| Change, 5 years | – | 177% |
| Beta (5Y) | 0.49 | 0.59 |
| Employees | 121 | 712 |
| StockData Score | ||
| Total score | 11 (better) | 10 |
| Valuation score | 0 | 1 (better) |
| Growth score | 4 (better) | 3 |
| Performance score | 4 (better) | 0 |
| Health score | 2 | 5 (better) |
| Dividend score | 1 | 1 |
| Valuation | ||
| P/E | 78.7× (better) | 108× |
| P/S | 4.7× (better) | 13.2× |
| P/B | 3.2× (better) | 3.6× |
| EV/EBITDA | 16.0× | – |
| PEG | – | 1.61 |
| Fair value | $23.17 | $86.63 |
| Margin of safety | −131% (better) | −171% |
| Growth | ||
| Revenue growth (TTM) | 16.4% | 37.6% (better) |
| Revenue growth, 5Y average | 16.2% | 18.7% (better) |
| EPS growth (TTM) | – | 23.2% |
| EPS growth, 5Y average | 53.1% (better) | −9.8% |
| Profitability | ||
| Gross margin | 21.2% | 39.5% (better) |
| Operating margin | 19.2% | – |
| Net margin | 4.8% | – |
| Return on equity | 4.0% | – |
| Return on invested capital | 16.5% | – |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | 6.2× | – |
| Altman Z-score | 3.89 | 4.99 (better) |
| Piotroski F-score | 7 | – |
| Dividends and buybacks | ||
| Dividend yield | 1.9% (better) | 1.3% |
| Payout ratio | 148% | – |
| Years of dividend growth | 0 | 2 (better) |
| Dividend growth, 5Y average | 3.1% (better) | 0.87% |
| Buyback yield | −11.5% | – |
| Shareholder yield | −9.6% | 1.3% (better) |
| Ownership | ||
| Held by institutions | 103% | 98.3% |
| Held by insiders | 0.63% | 0.04% |
| Insider net buying, 12 months | −$5.5M | $2.4M (better) |
| Short interest, % of float | 14.7% | 2.5% |
Go deeper
- AHR stock overview
- AHR income statement
- AHR valuation and score
- WELL stock overview
- WELL income statement
- WELL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.